Ventas
Annual Report 2017

Plain-text annual report

Note: Data per respective Q4 filings, press releases, supplemental disclosures and earnings conference calls for the years ended December 31, 2017 and 2016, unless otherwise disclosed. This Annual Report contains certain non-GAAP financial measures. Reconciliations of each of these non-GAAP financial measures are available on the Company’s website at https://www.ventasreit.com/investor-relations/non-gaap-financial-measures 1) EBITDA: Earnings Before Interest, Taxes, Depreciation and Amortization 2) IRF and LTAC: Inpatient Rehabilitation Facility and Long-Term Acute Care 3) Bloomberg: For period beginning 12/31/1999 and ending 12/31/2017. Ventas prices adjusted historically for spin-off of skilled nursing facilities (SNF) in 2015. 2017 ANNUAL REPORTExcellence. Sustained. FINANCIAL HIGHLIGHTS 2017 ANNUAL REPORT Income from Continuing Operations per diluted common share Normalized Funds from Operations (FFO) per diluted common share Reported FFO (NAREIT FFO) per diluted common share Net Debt to Adjusted Pro Form EBITDA1 Same Store Net Operating Income (NOI) Growth Total Indebtedness to Gross Value Fixed Charge Coverage 2017 2016 $1.80 $4.16 $4.22 5.7x 2.5% 38% 4.6x $1.59 $4.13 $4.13 5.7x 2.7% 38% 4.8x 29% 20% 6% 7% 1% 23% 7% 7% 1% Seniors Housing Operating (SHOP) Life Science and Innovation Centers Seniors Housing Triple Net (NNN) Health Systems Medical Office Buildings (MOB) Loans IRF and LTAC 2 Skilled Nursing Facilities (SNF) International Hospitals Net Income (per share) Dividend (per share) Revenue ($ millions) Cash Flow ($ millions) $3.78 2017 2016 $1.86 2015 $1.25 2017 2016 2015 $3.115 $2.965* $3.040 2017 2016 2015 $3,574 $3,444 $3,286 2017 2016 2015 $1,442 $1,372 $1,399 I O N B 2 $ ~ 01 02 VENTAS 4,673% BB HC REIT INDEX 731% MSCI US REIT INDEX 593% S&P 500 INDEX 158% ‘99 ’00 ‘01 ’02 ‘03 ’04 ‘05 ’06 ‘07 ’08 ‘09 ’10 ‘11 ’12 ‘13 ’14 ‘15 ’16 ‘17 *Excludes share distribution associated with the spin-off of Capital Care Properties (CCP) in 2015 FINANCIAL HIGHLIGHTSFINANCIAL SUMMARYCURATED HIGH-QUALITY DIVERSIFIED PROPERTY PORTFOLIORecord Financial ResultsTotal Shareholder Return32 2017 ANNUAL REPORT LETTER LETTER TO STAKEHOLDERSTwo Decades of Excellence. Sustained. 2017 was an outstanding year for Ventas, upholding our two decade history of excellence. Our superior business drove record revenues and cash flow. Our balanced, high-quality portfolio of life science, outpatient, seniors housing and other properties across the healthcare landscape delivered year-over-year earnings growth. We invested in our future, expanded our attractive university-based life science business, improved our financial strength, and profitably disposed of almost $1 billion in assets. In 2017, we also received numerous prestigious honors recognizing excellence in our important environmental, social and governance (ESG) efforts. We are proud of our inaugural inclusion on the Dow Jones Sustainability North America Index, and our designation as a “Winning Company” on the 2020 Women on Boards Gender Diversity Index. We were also named as one of Fortune’s “2018 World’s Most Admired Companies,” underscoring our industry leadership, commitment to ESG values, exemplary stewardship and world-class team.Even with all of our achievements, Ventas knows there is so much more opportunity in the large, fragmented real estate healthcare space which continues to be supported by compelling demographic trends. In our highly dynamic market, the opportunities are immense and our position is strong.In 2018, our 20th anniversary year, we remain relentlessly focused on delivering value to all our stakeholders. Our strategic principles—a diversified portfolio of superior properties across asset classes in our space, operated by leading care providers, innovative premier institutions and partners; financial strength and flexibility; a secure dividend supported by stable and growing cash flows; and leadership built on a foundation of integrity—will continue to produce reliable growth and income. Ventas has consistently advanced and improved through cycles because we know that every environment provides pathways to create value. Our cohesive and skilled team stays consistently prepared, productive and ready to seize opportunities. With two decades of proven strategic vision, exceptional foresight and innovation, and intelligent, timely capital allocation decisions, we expect to build upon our successful track record long into the future. Thanks to your ongoing trust and support, Ventas stands ready for the next twenty years.DEBRA A. CAFARO Chairman and Chief Executive Officer3 Positive gender diversity 10% higher than S&P 500 average (Source: Catalyst.org) Note: Data per respective Q4 filings, press releases, supplemental disclosures and earnings conference calls for the years ended December 31, 2017 and 2016, unless otherwise disclosed. This Annual Report contains certain non-GAAP financial measures. Reconciliations of each of these non-GAAP financial measures are available on the Company’s website at https://www.ventasreit.com/investor-relations/non-gaap-financial-measures 1) EBITDA: Earnings Before Interest, Taxes, Depreciation and Amortization 2) IRF and LTAC: Inpatient Rehabilitation Facility and Long-Term Acute Care 3) Bloomberg: For period beginning 12/31/1999 and ending 12/31/2017. Ventas prices adjusted historically for spin-off of skilled nursing facilities (SNF) in 2015. 2017 ACCOMPLISHMENTSof attractive value-creating investments and redevelopment commitments $1.8BCertified properties throughout the portfolio100+ LEED® AND ENERGY STAR®CEO Tenure TSR (Source: Bloomberg)2,360%community organizations supported through the Ventas Charitable Foundation80+ ~40% investment growthin University-adjacent Life Science PlatformONLY Healthcare REIT named in Fortune’s “2018 World’s Most Admired Companies”Named to Dow Jones Sustainability North America Index for 1st timeSame Store NOI Growth2.5% increased liquidity$1.4B increase in the dividend 5% YEAR-OVER-YEAR in profitable dispositions~$1B DIRECTORS Debra A. Cafaro Chairman and Chief Executive Officer Ventas, Inc. Jay M. Gellert Former President and Chief Executive Officer Health Net, Inc. Roxanne M. Martino Managing Partner OceanM19 Glenn J. Rufrano Chief Executive Officer VEREIT, Inc. James D. Shelton Presiding Director, Ventas, Inc. Lead Independent Director, Envision Healthcare Richard I. Gilchrist Senior Advisor The Irvine Company Walter C. Rakowich Former Chief Executive Officer Prologis, Inc. Melody C. Barnes Co-Founder and Principal MB Squared Solutions LLC Matthew J. Lustig Head of North America Investment Banking and Head of Real Estate and Lodging Lazard Frères & Co. LLC Robert D. Reed Former Senior Vice President and Chief Financial Officer Sutter Health EXECUTIVE OFFICERS Debra A. Cafaro Chairman and Chief Executive Officer Robert F. Probst Executive Vice President and Chief Financial Officer John D. Cobb Executive Vice President and Chief Investment Officer T. Richard Riney Executive Vice President, Chief Administrative Officer, General Counsel and Ethics and Compliance Officer Todd W. Lillibridge Executive Vice President, Medical Property Operations, and President and Chief Executive Officer, Lillibridge Healthcare Services, Inc. ANNUAL MEETING The Annual Meeting of Stockholders will convene May 15, 2018 at 8:00 a.m. (CDT) at 353 North Clark Street, James C. Tyree Auditorium, Chicago, IL 60654 TRANSFER AGENT & REGISTRAR EQ Shareowner Services P.O. Box 64874 St. Paul, MN 55164-0854 (800) 401 1957 STOCK INFORMATION INDEPENDENT AUDITORS NYSE Symbol: VTR As of March 16, 2018, Ventas had 356.3 million shares outstanding. KPMG LLP INFORMATION Copies of our 2017 Form 10-K and other filings with the Securities and Exchange Commission may be obtained without charge via our website at ventasreit.com MEMBER National Association of Real Estate Investment Trusts ventasreit.com CORPORATE HEADQUARTERS 500 North Hurstbourne Parkway Suite 200 Louisville, KY 40222 (502) 357 9000 353 North Clark Street Suite 3300 Chicago, IL 60654 (312) 660 3800 2745 North Dallas Parkway Suite 570 Plano, TX 75093 (972) 248 9100 For calls originating outside the United States and Canada, the international dialing code is +1. 

Continue reading text version or see original annual report in PDF format above